This mechanism contributes to weight loss, with clinical trials of semaglutide 2.4mg (Wegovy) demonstrating average weight reductions of 1015% of body weight over 1218 months
Acknowledgements The infrastructure for the NESDA study ( is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (ZonMw, grant number 10-000-1002) and financial contributions by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Leiden University Medical Center, Leiden University, GGZ Rivierduinen, University Medical Center Groningen, University of Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Rob Giel Onderzoekscentrum)
Without sufficient cortisol levels, we may be more at risk of becoming overly dependent on caffeine
Men who present with hour-glass deformity are also best served by plaque incision and grafting